Come up with a name for your new list and we'll add to it:
Proniras raised a round of funding on April 27, 2018. Investors include
U.S. Department of Health and Human Services.
Proniras Corporation is a Seattle-based biopharmaceutical company focused on developing tezampanel as a medical countermeasure for nerve agent-induced seizures.…